The natural history of benign prostatic hyperplasia

BJU International

Volumn 97, Issue SUPPL. 2, 2006, Pages 3-6

  Fitzpatrick, John M ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Acute urinary retention; BPH; LUTS; Natural history; Progression

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE; PLACEBO;

CLINICAL TRIAL; DETERIORATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; KIDNEY FAILURE; LONGITUDINAL STUDY; OUTCOMES RESEARCH; POST HOC ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION;

ADRENERGIC ALPHA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; CONTROLLED CLINICAL TRIALS; DISEASE PROGRESSION; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC HYPERPLASIA; QUINAZOLINES; TREATMENT OUTCOME; URINARY RETENTION;

EID: 33644824294     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06097.x     Document Type: Review

References (13)

1. Girman CJ Jacobsen SJ Tsukamoto T et al. Health-related quality of life associated with lower urinary tract symptoms in four countries Urology 1998 51 428 36
2. Emberton M Andriole GL de la Rosette J et al. Benign prostatic hyperplasia: a progressive disease of aging men Urology 2003 61 267 73
3. Chute CG Panser LA Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 1993 150 85 9
4. Roberts RO Jacobsen SJ Jacobsen DJ et al. Longitudinal changes in peak urinary flow rates in a community based cohort J Urol 2000 163 107 13
5. Jacobsen SJ Girman CJ Guess HA et al. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men J Urol 1996 155 595 600
6. Rhodes T Girman CJ Jacobson DJ et al. Longitudinal prostate volume in a community-based sample: 7-year follow-up in the Olmsted County study of urinary symptoms and health status among men J Urol 2000 163 248 A1105
7. Jacobsen SJ Jacobson DJ Girman CJ et al. Natural history of prostatism: risk factors for acute urinary retention J Urol 1997 158 481 7
8. Jacobsen SJ Jacobson DJ Girman CJ et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status J Urol 1999 162 1301 6
9. Meigs JB Barry MJ Giovannucci E Rimm EB Stampfer MJ Kawachi I Incidence rates and risk factors for acute urinary retention: The Health Professionals Follow-up Study J Urol 1999 162 376 82
10. McConnell JD Bruskewitz R Walsh P et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group N Engl J Med 1998 338 557 63
11. Bruskewitz R Girman CJ Fowler J et al. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study Urology 1999 54 670 8
12. McConnell JD Roehrborn CG Bautista OM et al. The long-term effect of doxazosin, finasteride and combination therapy on clinical progression of benign prostatic hyperplasia N Engl J Med 2003 349 2387 98
13. Roehrborn CG for the ALTESS Study Group Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study BJU Int 2006 97 734 41